Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Analgesic Research In Brief

This article was originally published in The Tan Sheet

Executive Summary

Ibuprofen in children: Compared with acetaminophen, ibuprofen may reduce risk of morbidity from asthma among children not known to be sensitive to aspirin or NSAIDs, Samuel Lesko, MD, et al., state in February Pediatrics. Analysis looked at 1,879 asthmatic children participating in the Boston University Fever Study. Acetaminophen 5 mg/kg, ibuprofen 5 mg/kg or ibuprofen 10 mg/kg were provided to parents of 632, 636 and 611 children on asthma medications, respectively. In the next month, children taking either dose of ibuprofen were 44% less likely to have an outpatient visit for asthma than children taking acetaminophen. Hospitalization rates were 37% lower among ibuprofen users, but deemed statistically insignificant. Since no placebo was used, researchers note it is impossible to determine whether "acetaminophen increased or ibuprofen decreased short-term asthma morbidity." Boots Healthcare International, which makes ibuprofen-containing Nurofen, sponsored the study...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093590

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel